138 related articles for article (PubMed ID: 35738616)
1. Pre-treatment CRP and Albumin Determines Prognosis for Unresectable Advanced Oesophageal Cancer.
Sohda M; Sakai M; Yamaguchi A; Watanabe T; Nakazawa N; Ubukata Y; Kuriyam K; Sano A; Yokobori T; Ogawa H; Shirabe K; Saeki H
In Vivo; 2022; 36(4):1930-1936. PubMed ID: 35738616
[TBL] [Abstract][Full Text] [Related]
2. A novel inflammation-based prognostic score in esophageal squamous cell carcinoma: the C-reactive protein/albumin ratio.
Wei XL; Wang FH; Zhang DS; Qiu MZ; Ren C; Jin Y; Zhou YX; Wang DS; He MM; Bai L; Wang F; Luo HY; Li YH; Xu RH
BMC Cancer; 2015 May; 15():350. PubMed ID: 25934640
[TBL] [Abstract][Full Text] [Related]
3. Glasgow Prognostic Score as a Prognostic Clinical Marker in T4 Esophageal Squamous Cell Carcinoma.
Ohira M; Kubo N; Masuda G; Yamashita Y; Sakurai K; Toyokawa T; Tanaka H; Muguruma K; Hirakawa K
Anticancer Res; 2015 Sep; 35(9):4897-901. PubMed ID: 26254385
[TBL] [Abstract][Full Text] [Related]
4. A novel inflammation-based prognostic score for patients with esophageal squamous cell carcinoma: the c-reactive protein/prognostic nutritional index ratio.
Chen S; Yang X; Feng JF
Oncotarget; 2016 Sep; 7(38):62123-62132. PubMed ID: 27557504
[TBL] [Abstract][Full Text] [Related]
5. The preoperative sensitive-modified Glasgow prognostic score is superior to the modified Glasgow prognostic score in predicting long-term survival for esophageal squamous cell carcinoma.
Tian R; Zhang F; Sun P; Wu J; Yan H; Wu AR; Zhang M; Jiang YL; Lu YH; Xu QY; Zhan XH; Zhang RX; Qian LT; He J
Oncotarget; 2016 Oct; 7(41):67485-67494. PubMed ID: 27528228
[TBL] [Abstract][Full Text] [Related]
6. Combined fibrinogen and neutrophil-lymphocyte ratio as a prognostic marker of advanced esophageal squamous cell carcinoma.
Kijima T; Arigami T; Uchikado Y; Uenosono Y; Kita Y; Owaki T; Mori S; Kurahara H; Kijima Y; Okumura H; Maemura K; Ishigami S; Natsugoe S
Cancer Sci; 2017 Feb; 108(2):193-199. PubMed ID: 27889946
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the prognostic value of tumour- and patient-related factors in patients undergoing potentially curative resection of oesophageal cancer.
Dutta S; Crumley AB; Fullarton GM; Horgan PG; McMillan DC
World J Surg; 2011 Aug; 35(8):1861-6. PubMed ID: 21538187
[TBL] [Abstract][Full Text] [Related]
8. Neutrophil-to-Lymphocyte Ratio as a Predictor of Postoperative Recurrence and Prognosis in Oesophageal Squamous Cell Carcinoma.
Ohsawa M; Hamai Y; Emi M; Ibuki Y; Kurokawa T; Yoshikawa T; Hirohata R; Kitasaki N; Okada M
Anticancer Res; 2022 Mar; 42(3):1499-1507. PubMed ID: 35220245
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of neutrophil-to-lymphocyte ratio in patients treated with concurrent chemoradiotherapy for locally advanced oesophageal cancer.
Yoo EJ; Park JC; Kim EH; Park CH; Shim CN; Lee HJ; Chung HS; Lee H; Shin SK; Lee SK; Lee CG; Lee YC
Dig Liver Dis; 2014 Sep; 46(9):846-53. PubMed ID: 24970014
[TBL] [Abstract][Full Text] [Related]
10. Treatment patterns and survival in advanced unresectable esophageal squamous cell cancer: A population-based study.
Pape M; Vissers PAJ; de Vos-Geelen J; Hulshof MCCM; Gisbertz SS; Jeene PM; van Laarhoven HWM; Verhoeven RHA
Cancer Sci; 2022 Mar; 113(3):1038-1046. PubMed ID: 34986523
[TBL] [Abstract][Full Text] [Related]
11. A Novel Inflammation-Based Prognostic Score, the C-Reactive Protein/Albumin Ratio Predicts the Prognosis of Patients with Operable Esophageal Squamous Cell Carcinoma.
Xu XL; Yu HQ; Hu W; Song Q; Mao WM
PLoS One; 2015; 10(9):e0138657. PubMed ID: 26390126
[TBL] [Abstract][Full Text] [Related]
12. C-reactive protein/albumin ratio is a poor prognostic factor of esophagogastric junction and upper gastric cancer.
Kudou K; Saeki H; Nakashima Y; Kamori T; Kawazoe T; Haruta Y; Fujimoto Y; Matsuoka H; Sasaki S; Jogo T; Hirose K; Hu Q; Tsuda Y; Kimura K; Ando K; Oki E; Ikeda T; Maehara Y
J Gastroenterol Hepatol; 2019 Feb; 34(2):355-363. PubMed ID: 30119141
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of an inflammation-based prognostic score in patients with inoperable gastro-oesophageal cancer.
Crumley AB; McMillan DC; McKernan M; McDonald AC; Stuart RC
Br J Cancer; 2006 Mar; 94(5):637-41. PubMed ID: 16479253
[TBL] [Abstract][Full Text] [Related]
14. Impact of inflammation-based prognostic score on survival after curative thoracoscopic esophagectomy for esophageal cancer.
Hirahara N; Matsubara T; Hayashi H; Takai K; Fujii Y; Tajima Y
Eur J Surg Oncol; 2015 Oct; 41(10):1308-15. PubMed ID: 26235238
[TBL] [Abstract][Full Text] [Related]
15. C-reactive protein to albumin ratio is a prognostic factor for patients with cStage II/III esophageal squamous cell cancer.
Otowa Y; Nakamura T; Yamamoto M; Kanaji S; Matsuda Y; Matsuda T; Oshikiri T; Sumi Y; Suzuki S; Kakeji Y
Dis Esophagus; 2017 Dec; 30(12):1-5. PubMed ID: 28881893
[TBL] [Abstract][Full Text] [Related]
16. C-Reactive Protein/Albumin Ratio Is an Independent Prognostic Predictor of Survival in Advanced Cancer Patients Receiving Palliative Care.
Zhang J; Zhang C; Li Q; Zhang J; Gu X; Zhao W; Chen M; Liu M; Zhang Z; Liao X; Cheng W
J Palliat Med; 2019 Dec; 22(12):1536-1545. PubMed ID: 31188054
[No Abstract] [Full Text] [Related]
17. Multidisciplinary Therapy for Locally Advanced Oesophageal Cancer With Special Reference to Surgical Conversion and Salvage.
Sohda M; Miyazaki T; Sakai M; Kumakura Y; Honjyo H; Hara K; Tanaka N; Yokobori T; Shirabe K
Anticancer Res; 2019 Jun; 39(6):3167-3175. PubMed ID: 31177163
[TBL] [Abstract][Full Text] [Related]
18. Inflammation-based prognostic scores predict the prognosis of locally advanced cervical esophageal squamous cell carcinoma patients receiving curative concurrent chemoradiotherapy: a propensity score-matched analysis.
Wu CC; Li SH; Lu HI; Lo CM; Wang YM; Chou SY; Chen YH
PeerJ; 2018; 6():e5655. PubMed ID: 30258731
[TBL] [Abstract][Full Text] [Related]
19. Effects of nutritional support on short-term clinical outcomes and immune response in unresectable locally advanced oesophageal squamous cell carcinoma.
Chen F; Fang J; Wang H; Song T; Zhu W; Wu M; Wu Y
Eur J Cancer Care (Engl); 2018 Mar; 27(2):e12818. PubMed ID: 29345017
[TBL] [Abstract][Full Text] [Related]
20. Pre-treatment maximal oesophageal wall thickness is independently associated with response to chemoradiotherapy in patients with T3-4 oesophageal squamous cell carcinoma.
Li SH; Rau KM; Lu HI; Wang YM; Tien WY; Liang JL; Lin WC
Eur J Cardiothorac Surg; 2012 Dec; 42(6):958-64. PubMed ID: 22466694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
